サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：組織検査・細胞検査の世界市場－成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1149152

組織検査・細胞検査の世界市場－成長、将来展望、競合分析（2022年～2030年）

Histology and Cytology Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
組織検査・細胞検査の世界市場－成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月03日
発行: Acute Market Reports
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の組織検査・細胞検査の市場規模は、2022年から2030年の予測期間中に13.6％のCAGRで成長すると予想されています。公衆衛生意識の高まり、細胞検査に対する需要の高まり、組織診断キットの技術的進歩、慢性疾患の診断における組織診断キットの開発・商業化に向けた主要企業の戦略的提携は、組織検査・細胞検査市場の成長を促進しています。

当レポートでは、世界の組織検査・細胞検査市場について調査分析し、ビジネス展望、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
    • レポートの目的
    • 対象者
    • 主な製品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ－2次調査
    • フェーズⅡ－1次調査
    • フェーズⅢ－専門家による審査
    • 仮定
    • 採用されたアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の組織検査・細胞検査市場
  • 世界の組織検査・細胞検査市場（100万米ドル）（2021年）：検査別
  • 世界の組織検査・細胞検査市場（100万米ドル）：地域別
  • COVID-19の影響
  • 魅力的な投資提案（2021年）：地域別
  • 競合分析
    • 主要な組織検査・細胞検査市場ベンダーの市場ポジショニング
    • 組織検査・細胞検査市場のベンダーが採用する戦略
    • 主要な業界戦略

第3章 組織検査・細胞検査市場：ビジネス展望と市場力学

  • イントロダクション
  • 世界の組織検査・細胞検査市場金額（100万米ドル）（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーの力
    • バイヤーの力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的
    • 経済的
    • 技術的
    • 法的
    • 社会的

第4章 組織検査・細胞検査市場、米ドル（100万）（2020年～2030年）：検査別

  • 市場概要
  • 成長と収益分析：2021年と2030年の比較
  • 市場セグメンテーション
    • 細胞検査
    • 組織検査

第5章 北米の組織検査・細胞検査市場、米ドル（100万）（2020年～2030年）

第6章 英国および欧州連合の組織検査・細胞検査市場、米ドル（100万）（2020年～2030年）

第7章 アジア太平洋の組織検査・細胞検査市場、米ドル（100万）（2020年～2030年）

第8章 ラテンアメリカの組織検査・細胞検査市場、米ドル（100万）（2020年～2030年）

第9章 中東およびアフリカの組織検査・細胞検査市場、米ドル（100万）（2020年～2030年）

第10章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Becton Dickinson and Company
  • Danaher Corporation
  • F.Hoffman-La Roche Ltd.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Life Technologies Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare
図表

List of Tables

  • TABLE 1 Global Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 2 Global Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 3 North America Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 4 North America Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 9 Latin America Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 10 Latin America Histology and Cytology Market By Cytology, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Histology and Cytology Market By Examination, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Histology and Cytology Market By Cytology, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Histology and Cytology Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Histology and Cytology Market: Quality Assurance
  • FIG. 5 Global Histology and Cytology Market, By Examination, 2021
  • FIG. 6 Global Histology and Cytology Market, By Geography, 2021
  • FIG. 7 Global Histology and Cytology Market, By Examination, 2021 Vs 2030, %
  • FIG. 8 U.S. Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 9 Canada Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 10 Rest of North America Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 11 UK Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 12 Germany Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 13 Spain Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 14 Italy Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 15 France Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of Europe Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 17 China Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 18 Japan Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 19 India Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 20 Australia Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 21 South Korea Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Asia Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 23 Brazil Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 24 Mexico Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Latin America Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 26 GCC Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 27 Africa Histology and Cytology Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Middle East and Africa Histology and Cytology Market (US$ Million), 2020 - 2030
目次
Product Code: 138682-08-22

Industry Outlook

The histology and cytology market is annual growth rate (CAGR) of 13.6% during the forecast period from 2022 to 2030. As per the research citings provided by World Health Organization (WHO) the global burden of cancer is approximately 18.1 million new cases and with 9.6 million deaths in 2022. The major factors responsible for the occurrence of chronic disease are increasing consumption of tobacco, alcohol, junk food, sedentary lifestyle and stress. Researchers are of the view that in the light of in the era of modern technology, utilization of sophisticated technology pertaining to histology and cytology examinations will help in promoting early diagnosis and curtailing morbidity associated with chronic ailments. Rising public health awareness will further bolster the histology and cytology market growth during the forecast period from 2022 to 2030.

Increasing demand for cell screening and inherent features such as low cost, high sensitivity and adequate specificity drive the cytology examination market growth

Cytology examination are dominating the type of examination segment for histology and cytology market. The growth factors creating a positive impact in the cytology examination market growth are increasing demand for cell screening in breast and cervical cancer patients. Inherent features such as low cost, high sensitivity and adequate specificity associated with cytology examination procedure further fortify its market growth. Histology examination procedures will be growing at a rapid pace on account of technological advancement in tissue diagnostic kits and strategic collaboration among major players for further development and commercialization of histology examination procedures in diagnosis of chronic ailments.

Significant rise in cancer diagnosis and increasing public health awareness drive the market growth in North America

North America currently holds 35% market share and is the leading regional market for histology and cytology market. The major factors controlling its market growth are significant rise in cancer diagnosis and increasing public health awareness. As per the statistics provided by Center for Disease Control and Prevention (CDC) in 2021, the number of adults been diagnosed with cancer were 23.2 million which represents 9.4% of the total population. Existence of key players such as Abbott Laboratories, Inc., Hologic, Inc., Thermo Fisher Scientific, Inc. etc. provide a positive impetus to the histology and cytology market growth in North America region. Europe holds 30% market share on account of rising prevalence of cancer and supportive environment provided by European Medical Agency (EMA) for histology and cytology diagnostic procedures. Asia Pacific is accountable for 16% share and is keen to register outstanding growth owing to rampant growth in healthcare infrastructure development and adoption to sophisticated diagnostic technology pertaining to cytology and histology studies.

Biotechnology companies specializing in histology and cytology market are: Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, F.Hoffman-La Roche Ltd., Trivitron Healthcare, Hologic, Inc., Koninklijke Philips N.V. and Life Technologies Corporation.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Histology and Cytology market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Histology and Cytology market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Examination

  • Cytology
    • Cervical Cancer
    • Breast Cancer
    • Other Cancers
  • Histology

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Histology and Cytology market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Histology and Cytology market?
  • Which is the largest regional market for Histology and Cytology market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Histology and Cytology market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Histology and Cytology market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Histology and Cytology Market
  • 2.2. Global Histology and Cytology Market, By Examination, 2021 (US$ Million)
  • 2.3. Global Histology and Cytology Market, By Geography, 2021 (US$ Million)
  • 2.4. Impact of Covid 19
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Competitive Analysis
    • 2.6.1. Market Positioning of Key Histology and Cytology Market Vendors
    • 2.6.2. Strategies Adopted by Histology and Cytology Market Vendors
    • 2.6.3. Key Industry Strategies

3. Histology and Cytology Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Histology and Cytology Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Cytology
      • 4.3.1.1. Cervical Cancer
      • 4.3.1.2. Breast Cancer
      • 4.3.1.3. Other Cancers
    • 4.3.2. Histology

5. North America Histology and Cytology Market, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 5.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 5.3.1.North America
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
      • 5.3.1.3. Rest of North America

6. UK and European Union Histology and Cytology Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 6.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.UK and European Union
      • 6.3.1.1. UK
      • 6.3.1.2. Germany
      • 6.3.1.3. Spain
      • 6.3.1.4. Italy
      • 6.3.1.5. France
      • 6.3.1.6. Rest of Europe

7. Asia Pacific Histology and Cytology Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 7.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.Asia Pacific
      • 7.3.1.1. China
      • 7.3.1.2. Japan
      • 7.3.1.3. India
      • 7.3.1.4. Australia
      • 7.3.1.5. South Korea
      • 7.3.1.6. Rest of Asia Pacific

8. Latin America Histology and Cytology Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 8.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Latin America
      • 8.3.1.1. Brazil
      • 8.3.1.2. Mexico
      • 8.3.1.3. Rest of Latin America

9. Middle East and Africa Histology and Cytology Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Histology and Cytology Market: By Examination, 2020-2030, USD (Million)
  • 9.3.Histology and Cytology Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Middle East and Africa
      • 9.3.1.1. GCC
      • 9.3.1.2. Africa
      • 9.3.1.3. Rest of Middle East and Africa

10. Company Profile

  • 10.1. Abbott Laboratories, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Initiatives
  • 10.2. Becton Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Initiatives
  • 10.3. Danaher Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Initiatives
  • 10.4. F.Hoffman-La Roche Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Initiatives
  • 10.5. Hologic, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Initiatives
  • 10.6. Koninklijke Philips N.V.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Initiatives
  • 10.7. Life Technologies Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Initiatives
  • 10.8. Sysmex Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Initiatives
  • 10.9. Thermo Fisher Scientific, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Initiatives
  • 10.10. Trivitron Healthcare
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Portfolio
    • 10.10.4. Strategic Initiatives